Rezolute, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Rezolute, Inc. on August 5, 2019, covering events that occurred on July 31, 2019. The filing details the entry into material definitive employment agreements, the adoption of a new stock option plan, significant equity grants to executive officers, and retroactive salary and bonus adjustments.
Key Financial Metrics and Compensation Details
The filing does not provide consolidated revenue, profit, cash flow, or debt metrics. Financial data is limited to specific compensation arrangements and equity valuations:
- Executive Salaries: Keith Vendola (CFO) base salary set at $365,000; Seline Miller (CAO) base salary set at $265,000. Nevan Elam (CEO) salary increased to $490,000 (effective June 1, 2019).
- Equity Grants: Options granted with an exercise price of $0.29 per share. Total shares granted to named executives: 22,700,000.
- Cash Bonuses: Aggregate retroactive cash bonus payments of $447,919 approved for three officers based on 2017 and 2018 targets.
- Consulting Fees: $29,625 paid to Setren & Associates for compensation consulting services.
Material Changes and Corporate Actions
The following material changes were executed on July 31, 2019:
- New Employment Agreements: Formalized terms for CFO Keith Vendola and CAO Seline Miller, including base pay, performance bonuses (up to 30% and 35% of base, respectively), and discretionary bonuses.
- 2019 Non-Qualified Stock Option Plan: Adopted a plan authorizing the grant of up to 15,000,000 shares of common stock to employees, directors, and consultants.
- Significant Option Grants:
- Nevan Elam (CEO): 15,000,000 shares
- Sankaram Mantripragada (CSO): 3,500,000 shares
- Keith Vendola (CFO): 3,000,000 shares
- Seline Miller (CAO): 1,200,000 shares
- CEO Compensation Adjustment: Nevan Elam's base salary was increased from $450,000 to $490,000, effective retroactively to June 1, 2019.
Outlook, Risks, and Vesting Conditions
Equity grants include specific performance milestones that act as contingencies for vesting:
- Time-Based Vesting: 25% vests immediately (for employees with >1 year tenure) or on the one-year anniversary; the remainder vests monthly over 36 months.
- Milestone-Based Vesting: A portion of options vests monthly upon meeting specific conditions:
- Listing on a national stock exchange (Nasdaq, NYSE, or equivalent).
- Stock price exceeding $0.58 per share for 20 trading days within a 30-day period within 4 years of the grant.
- Completion of at least one year of employment.
Key Facts for Investor Verification
- Verify the total number of authorized shares under the 2019 Plan (15,000,000) against the immediate grants (22,700,000 to named executives) to assess potential dilution or plan adjustments.
- Confirm the company's current stock price relative to the $0.58 milestone required for partial option vesting.
- Review the July 30, 2019 Form 8-K referenced in the text to understand the financing round that established the $0.29 exercise price.
- Monitor the company's progress toward a national stock exchange listing, a key condition for equity vesting.